What is the role of the enteric commensal flora in IBD?
Abstract
Infectious diseases are produced by specific microbial agents that possess the capacity of transmitting the disease to susceptible individuals. An infectious origin of Crohn's disease (CD) or ulcerative colitis (UC) is not supported by such a criterion since direct transmission of these diseases has never been documented. However, there is a substantial body of evidence implicating the commensal enteric bacteria in the pathogenesis of both CD and UC. Luminal bacteria appear to provide the stimulus for immuno-inflammatory responses leading to mucosal injury.1,2 The normal mucosal defense is based mainly on the production of IgA antibodies that are secreted into the gut lumen where they neutralize microbes, thus avoiding mucosal inflammation.2 In IBD, however, mucosal production of IgG antibodies against intestinal bacteria is highly increased, and mucosal defense relies on both IgG-mediated responses within the tissue and hyperactivated lymphocytes in the lamina propria reacting against bacterial antigens.1,–3 These combined events result in inflammation and tissue injury. The altered immune response is not specifically addressed or polarized toward a single group of potential pathogens, but involves a large and undefined number of commensal species belonging to the common enteric flora. Several factors may contribute to the abnormal reactivity of the mucosal immune system against enteric bacteria, and these include genetic susceptibility, a defect in mucosal barrier function, and a microbial imbalance in the gut ecosystem.1 The term “microflora” or “microbiota” refers to the community of living microorganisms assembled in a particular ecological niche of a host individual. Microbial communities act as a single ecosystem and are capable of adapting to radical habitat alterations by altering community physiology and composition. In this way they are able to maintain stability in structure and function over time. The human gut is the natural habitat for a large, diverse, and dynamic population of microorganisms that over millennia have adapted to live on the mucosal surfaces or in the lumen.3 The number of resident bacteria increases along the small bowel, from ≈104 in the jejunum to 107 colony-forming units per gram of luminal content at the ileal end. The large intestine is the most heavily populated organ, where several hundred grams of bacteria are harbored at densities around 1012 colony-forming units per gram of luminal content. Over 50% of bacteria cells that are observed by microscopic examination of fecal specimens cannot be grown in culture. Molecular biological techniques based on the sequence diversity of the bacterial genome are now being used to characterize noncultivable bacteria. Studies on the fecal microbiota have highlighted the diversity of the flora between individuals. Each individual harbors his or her own distinctive pattern of bacterial composition. This pattern appears to be determined at least in part by the host genotype, because similarity in fecal bacterial species is much higher within twins than genetically unrelated couples that share environment and dietary habits. In healthy adults the fecal composition is host-specific and stable over time, but temporal fluctuations due to environmental factors can be detected and may involve up to 20% of the strains. Bacterial composition in the lumen varies from the cecum to the rectum, and fecal samples do not reflect luminal contents at proximal segments. Nevertheless, the community of mucosal-associated bacteria is highly stable from the terminal ileum to the large bowel in a given individual (95% similarity between the different anatomical locations). The interaction between gut bacteria and their host is a symbiotic relationship mutually beneficial for both partners. The host provides a nutrient-rich habitat and the bacteria confer important benefits to the host. Functions of the microbiota include nutrition (fermentation of nondigestible substrates that results in production of short chain fatty acids, absorption of ions, production of amino acids, and vitamins), protection (the barrier effect that prevents invasion by alien microbes), and important trophic effects on the intestinal epithelium and the immune system (development and homeostasis of local and systemic immunity). Animals bred in a germ-free environment show lower densities of lymphoid cells in the gut mucosa and lower levels of serum immunoglobulins. Exposure to commensal microbes rapidly expands the number of mucosal lymphocytes and increases the size of germinal centers in lymphoid follicles. Immunoglobulin-producing cells appear in the lamina propria, and there is a significant increase in serum immunoglobulin levels. Some commensal bacteria seem to play a dominant role in the induction of regulatory T cells in gut lymphoid follicles. Regulatory pathways mediated by regulatory T cells are essential homeostatic mechanisms, through which the host can tolerate the massiv
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A deregulated immune response against commensal gut bacteria, in which local tolerance mechanisms towards commensal microbes seem to be impaired, may contribute to the onset or perpetuation of IBD.
“A deregulated immune response against commensal gut bacteria, in which local tolerance mechanisms towards commensal microbes seem to be impaired, may contribute to the onset or perpetuation of IBD [31] .”
From Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis (2014) · cites this paper as [31]
Cites
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277 · see citing works
Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311 · see citing works
The fundamental basis of inflammatory bowel disease
Strober, W., Fuss, I. J., & Mannon, P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30587 · Cited by 1,310 · see citing works
Swidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P., & Lochs, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3380-3389.2005 · Cited by 894 · see citing works
Specificities of the fecal microbiota in inflammatory bowel disease
Sokol, H., Seksik, P., Rigottier‐Gois, L., Lay, C., Lepage, P., Podglajen, I., Marteau, P. R., & Dore, J. M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000200323.38139.c6 · Cited by 447 · see citing works
The love–hate relationship between bacterial polysaccharides and the host immune system
Mazmanian, S. K., & Kasper, D. L. (2006) · Nature reviews. Immunology · doi:10.1038/nri1956 · Cited by 357 · see citing works
Mucosal and Invading Bacteria in Patients with Inflammatory Bowel Disease Compared with Controls
Kleessen, B., Kroesen, A. J., Buhr, H. J., & Blaut, M. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320378220 · Cited by 351 · see citing works
Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission
Martinez, C., Antolin, M., Santos, J., Torrejon, A., Casellas, F., Borruel, N., Guarner, F., & Malagelada, J.-R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01592.x · Cited by 208 · see citing works
Self-citationThe B-Cell System in Inflammatory Bowel Disease
Brandtzæg, P., Carlsen, H. S., & Halstensen, T. S. (2006) · Advances in experimental medicine and biology · doi:10.1007/0-387-33778-4_10 · Cited by 138 · see citing works
The intestinal flora in inflammatory bowel disease: normal or abnormal?
Guarner, F. (2005) · PubMed · Cited by 69 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Manichanh, C., Borruel, N., Casellas, F., & Guarner, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.152 · Cited by 1,160 · see citing works
Self-citationIntestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533 · see citing works
Linking the gut microbiota to human health
Robles, V., & Guarner, F. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512005235 · Cited by 307 · see citing works
Self-citationHooda, S., Boler, B. M. V., Serao, M. C. R., Brulc, J. M., Staeger, M. A., Boileau, T. W., Dowd, S. E., Fahey, G. C., & Swanson, K. S. (2012) · The Journal of Nutrition · doi:10.3945/jn.112.158766 · Cited by 272 · see citing works
The Role of Macrophages and Dendritic Cells in the Initiation of Inflammation in IBD
Steinbach, E. C., & Plevy, S. E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182a69dca · Cited by 250 · see citing works
Shmuel-Galia, L., Humphries, F., Lei, X., Ceglia, S., Wilson, R., Jiang, Z., Ketelut-Carneiro, N., Foley, S. E., Pechhold, S. B., Houghton, J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.008 · Cited by 149 · see citing works
Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease
Cantorna, M. T., McDaniel, K. L., Bora, S. A., Chen, J., & James, J. L. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214523890 · Cited by 140 · see citing works
Chen, P., Xu, H., Tang, H., Zhao, F., Yang, C., Kwok, L., Cong, C., Wu, Y., Zhang, W., Zhou, X., et al. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13661 · Cited by 85 · see citing works
NOD-like receptors in intestinal homeostasis and epithelial tissue repair
Parlato, M., & Yeretssian, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069594 · Cited by 79 · see citing works
Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohnʼs Disease
Assa, A., Butcher, J., Li, J. S. Y., Elkadri, A. A., Sherman, P. M., Muise, A. M., Stintzi, A. P., & Mack, D. R. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000776 · Cited by 78 · see citing works
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis
Chen, W.-X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15657 · Cited by 51 · see citing works
Harnessing Regulatory T Cells for the Treatment of Inflammatory Bowel Disease
Geem, D., Harusato, A., Flannigan, K. L., & Denning, T. L. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000343 · Cited by 49 · see citing works
Tanaka, Y., & Benno, Y. (2014) · Microbiology and Immunology · doi:10.1111/1348-0421.12220 · Cited by 40 · see citing works
Robust Microbiota-Based Diagnostics for Inflammatory Bowel Disease
Eck, A., de Groot, E. F. J., de Meij, T. G. J., Welling, M., Savelkoul, P. H. M., & Budding, A. E. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00162-17 · Cited by 29 · see citing works
Hetzenecker, A., Seidl, M., Kosovac, K., Herfarth, H. H., Kellermeier, S., Obermeier, F., Falk, W., Schöelmerich, J., Hausmann, M., & Rogler, G. (2012) · Digestion · doi:10.1159/000336353 · Cited by 22 · see citing works
Fecal transplantation indications in ulcerative colitis. Preliminary study
Laszlo, M., Ciobanu, L., Andreica, V., & Pascu, O. (2016) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-613 · Cited by 9 · see citing works
Clinical Conditions Associated With Bacterial Overgrowth
Shah, A., & Holtmann, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54843-4.00006-4 · Cited by 8 · see citing works
Gut Microbiota Dysbiosis and Chronic Intestinal Inflammation
Sarmento, A., & Simões, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00057-7 · Cited by 2 · see citing works
Nutritional and Botanical Approaches for Inflammatory Bowel Disease
Lucius, K. (2021) · Alternative and Complementary Therapies · doi:10.1089/act.2021.29331.klu · Cited by 1 · see citing works
Ali, A., Islam, N., Fakir, N. I., Kabir, A., Sharmin, M., Islam, T., Rahman, M., Badal, F. A., & Taher, A. (2024) · International Journal of Immunology · doi:10.11648/j.iji.20241201.12 · Cited by 1 · see citing works
Gut Microbiota and Risk for Atherosclerosis: Current Understanding of the Mechanisms
Dutta, B., Biswas, C., Arya, R. K., & Rahaman, S. O. (2020) · Springer eBooks · doi:10.1007/978-3-030-47384-6_8
- Authors
- Guarner, F.
- Affiliations
- Vall d'Hebron Hospital Universitari (ES)
- Corresponding author
- Guarner, Francisco
- ORCID
- Guarner, Francisco
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10
- Volume
- 14
- Issue
- Supplement
- Pages
- S83-S84
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2123129380
- Cited by
- 21
- References
- 10
- Citations by year
- 2024: 1 · 2021: 3 · 2020: 1 · 2019: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 5 · 2013: 2 · 2012: 3
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, Crohn's disease
- MeSH terms
- Bacteria, Anaerobic, Bacterial Adhesion, Humans, Intestinal Mucosa, Colony Count, Microbial, Inflammatory Bowel Diseases, Immunity, Mucosal, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review